232 related articles for article (PubMed ID: 23891163)
21. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
[TBL] [Abstract][Full Text] [Related]
22. Glucosinolate catabolism during postharvest drying determines the ratio of bioactive macamides to deaminated benzenoids in Lepidium meyenii (maca) root flour.
Esparza E; Yi W; Limonchi F; Cosio EG
Phytochemistry; 2020 Nov; 179():112502. PubMed ID: 32871537
[TBL] [Abstract][Full Text] [Related]
23. Luciferin Amides Enable in Vivo Bioluminescence Detection of Endogenous Fatty Acid Amide Hydrolase Activity.
Mofford DM; Adams ST; Reddy GS; Reddy GR; Miller SC
J Am Chem Soc; 2015 Jul; 137(27):8684-7. PubMed ID: 26120870
[TBL] [Abstract][Full Text] [Related]
24. Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase.
Scott CW; Tian G; Yu XH; Paschetto KA; Wilkins DE; Meury L; Cao CQ; Varnes J; Edwards PD
Eur J Pharmacol; 2011 Sep; 667(1-3):74-9. PubMed ID: 21645511
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
26. Nonempirical energetic analysis of reactivity and covalent inhibition of fatty acid amide hydrolase.
Chudyk EI; Dyguda-Kazimierowicz E; Langner KM; Sokalski WA; Lodola A; Mor M; Sirirak J; Mulholland AJ
J Phys Chem B; 2013 Jun; 117(22):6656-66. PubMed ID: 23654226
[TBL] [Abstract][Full Text] [Related]
27. Effects of synthetic alkamides on Arabidopsis fatty acid amide hydrolase activity and plant development.
Faure L; Cavazos R; Khan BR; Petros RA; Koulen P; Blancaflor EB; Chapman KD
Phytochemistry; 2015 Feb; 110():58-71. PubMed ID: 25491532
[TBL] [Abstract][Full Text] [Related]
28. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
Tsuboi K; Hilligsmann C; Vandevoorde S; Lambert DM; Ueda N
Biochem J; 2004 Apr; 379(Pt 1):99-106. PubMed ID: 14686878
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
Hicks JW; Parkes J; Sadovski O; Tong J; Houle S; Vasdev N; Wilson AA
Nucl Med Biol; 2013 Aug; 40(6):740-6. PubMed ID: 23731552
[TBL] [Abstract][Full Text] [Related]
30. A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.
Gattinoni S; Simone CD; Dallavalle S; Fezza F; Nannei R; Battista N; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
Bioorg Med Chem Lett; 2010 Aug; 20(15):4406-11. PubMed ID: 20591666
[TBL] [Abstract][Full Text] [Related]
31. Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase.
Patricelli MP; Cravatt BF
Biochemistry; 2001 May; 40(20):6107-15. PubMed ID: 11352748
[TBL] [Abstract][Full Text] [Related]
32. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
33. O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.
Colombano G; Albani C; Ottonello G; Ribeiro A; Scarpelli R; Tarozzo G; Daglian J; Jung KM; Piomelli D; Bandiera T
ChemMedChem; 2015 Feb; 10(2):380-95. PubMed ID: 25338703
[TBL] [Abstract][Full Text] [Related]
34. Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites.
Tichenor MS; Keith JM; Jones WM; Pierce JM; Merit J; Hawryluk N; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Wilson SJ; Wennerholm ML; Woestenborghs F; Beerens D; Luo L; Brown SM; Boeck MD; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2012 Dec; 22(24):7357-62. PubMed ID: 23141911
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
36. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure.
Lodola A; Rivara S; Mor M
Adv Protein Chem Struct Biol; 2011; 85():1-26. PubMed ID: 21920320
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications.
Quistad GB; Sparks SE; Segall Y; Nomura DK; Casida JE
Toxicol Appl Pharmacol; 2002 Feb; 179(1):57-63. PubMed ID: 11884237
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.
Butini S; Gemma S; Brindisi M; Maramai S; Minetti P; Celona D; Napolitano R; Borsini F; Cabri W; Fezza F; Merlini L; Dallavalle S; Campiani G; Maccarrone M
Bioorg Med Chem Lett; 2013 Jan; 23(2):492-5. PubMed ID: 23237837
[TBL] [Abstract][Full Text] [Related]
39. Novel propanamides as fatty acid amide hydrolase inhibitors.
Deplano A; Morgillo CM; Demurtas M; Björklund E; Cipriano M; Svensson M; Hashemian S; Smaldone G; Pedone E; Luque FJ; Cabiddu MG; Novellino E; Fowler CJ; Catalanotti B; Onnis V
Eur J Med Chem; 2017 Aug; 136():523-542. PubMed ID: 28535469
[TBL] [Abstract][Full Text] [Related]
40. Latest advances in the discovery of fatty acid amide hydrolase inhibitors.
Bisogno T; Maccarrone M
Expert Opin Drug Discov; 2013 May; 8(5):509-22. PubMed ID: 23488865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]